Latest Findings in Immunoglobulin Y Technologies and Applications
International Journal of Molecular Sciences · 02.07.2025 · 26 (13) · 6380
DOI: 10.3390/ijms26136380 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.07.2025. Verfasst von Robert Capotă und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Veterinary Medicine, "Ion Ionescu de la Brad" Iasi University of Life Sciences, 700490 Iasi, Romania. Hauptthemen laut MEDLINE: Immunoglobulins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immunoglobulin Y (IgY), the major antibody class in birds, has gained increasing attention in recent years as a versatile and ethically sustainable alternative to mammalian immunoglobulins. IgY has demonstrated strong potential in diagnostics, prophylaxis, and therapy across a wide range of fields, including infectious diseases, allergy management, oral health, and food safety. Its applications in animal health—particularly in poultry, livestock, and companion animals—further underscore its relevance within the One Health framework. This review provides a comprehensive synthesis of IgY technology, starting with its physiological role in maternal immunity and the structural characteristics that distinguish it from mammalian immunoglobulin G (IgG). This review outlines current strategies for IgY production and purification. It also provides an overview of its biomedical and veterinary applications, including its use in diagnostics, prevention, and treatment—such as for SARS-CoV-2—primarily based on studies published in the past five years. The final section addresses the current limitations of IgY technology, such as variability in protocols, stability challenges, and the need for safety assessment, while highlighting the importance of harmonized guidelines to support broader implementation. With growing scientific interest, expanding clinical research, and increasing availability of commercial products, IgY is well positioned to become a valuable immunobiological tool for both human and veterinary applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Veterinary Medicine, "Ion Ionescu de la Brad" Iasi University of Life Sciences, 700490 Iasi, Romania.
ORCID-Profile: Robert Capotă, Dana Ciaușu-Sliwa, Valentin Năstasă, Mihai Mareș
Zitieren
APA
Capotă, R., Ciaușu-Sliwa, D., Bostănaru-Iliescu, A. C., Năstasă, V., & Mareș, M. (2025). Latest Findings in Immunoglobulin Y Technologies and Applications. International Journal of Molecular Sciences, 26(13), 6380. https://doi.org/10.3390/ijms26136380
Vancouver
Capotă R, Ciaușu-Sliwa D, Bostănaru-Iliescu AC, Năstasă V, Mareș M. Latest Findings in Immunoglobulin Y Technologies and Applications. International Journal of Molecular Sciences. 2025;26(13):6380. doi:10.3390/ijms26136380
BibTeX
@article{Capot2025,
author = {Capotă, Robert and Ciaușu-Sliwa, Dana and Bostănaru-Iliescu, Andra-Cristina and Năstasă, Valentin and Mareș, Mihai},
title = {Latest Findings in Immunoglobulin Y Technologies and Applications},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {13},
pages = {6380},
doi = {10.3390/ijms26136380}
}
EUVIMED